Luliconazole 1% w/w
Each lami tube contains 10 gm of cream
Luliconazole, demonstrates broad-spectrum antifungal activity by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. This disruption compromises the integrity of the fungal cell wall, leading to cellular damage and subsequent elimination. It provides a smooth and easily applicable texture, ensuring optimal coverage of affected skin areas. This makes it a user-friendly solution for individuals dealing with fungal infections, offering both convenience and effectiveness. We offer this product under the brand name Mizuli cream.
Luliconazole, the active ingredient in Mizuli Cream, exerts its antifungal effects by inhibiting the enzyme lanosterol demethylase. This enzyme is crucial for the synthesis of ergosterol, an essential component of fungal cell membranes. By disrupting ergosterol production, Luliconazole weakens the fungal cell wall, leading to structural instability, leakage, and eventual cell death. This targeted mechanism ensures Mizuli's efficacy against a wide range of pathogenic fungi.
Absorption
The absorption of Luliconazole into the skin, allowing for effective distribution in the affected areas. Luliconazole exhibits minimal systemic absorption, minimizing the risk of systemic side effects.
Distribution:
While the cream base ensures local distribution, Luliconazole's affinity for skin tissues contributes to its effective presence at the site of infection. This targeted distribution enhances the antifungal activity of Mizuli.
Excretion:
The minimal systemic absorption of Luliconazole results in a negligible presence in the systemic circulation. Excretion occurs predominantly through non-systemic routes, emphasizing its localized action.